Monday, 9 January 2023
'Covaxin found to be well tolerated and safe in US study'
Ocugen, Bharat Biotech’s US and Canada partner for Covid-19 vaccine Covaxin, on Monday said the Indian vaccine candidate was found to be well-tolerated in vaccine-naïve individuals and those previously vaccinated with mRNA vaccines in the United States.
from Times of India https://timesofindia.indiatimes.com/india/ocugen-bharat-biotech-covid-vaccine-covaxin-meets-main-goals-in-us-trial/articleshow/96857805.cms
from Times of India https://timesofindia.indiatimes.com/india/ocugen-bharat-biotech-covid-vaccine-covaxin-meets-main-goals-in-us-trial/articleshow/96857805.cms
Subscribe to:
Post Comments
(
Atom
)
No comments :
Post a Comment